High Tower Advisors, LLC Reata Pharmaceuticals Inc Transaction History

High Tower Advisors, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$79.22 - $105.37 $111,224 - $147,939	-1,404 Reduced 2.87%	47,574 $4.85 Million
Q1 2023 May 11, 2023	SELL	$30.85 - $93.17 $105,414 - $318,361	-3,417 Reduced 6.52%	48,978 $4.45 Million
Q4 2022 Feb 08, 2023	SELL	$22.15 - $42.11 $83,173 - $158,123	-3,755 Reduced 6.69%	52,395 $1.99 Million
Q3 2022 Nov 09, 2022	BUY	$19.41 - $36.49 $2,620 - $4,926	135 Added 0.24%	56,150 $1.41 Million
Q2 2022 Aug 10, 2022	BUY	$20.71 - $36.5 $31,065 - $54,750	1,500 Added 2.75%	56,015 $1.71 Million
Q1 2022 May 12, 2022	SELL	$24.12 - $39.6 $7,428 - $12,196	-308 Reduced 0.56%	54,515 $1.79 Million
Q4 2021 Feb 10, 2022	SELL	$25.61 - $110.96 $109,277 - $473,466	-4,267 Reduced 7.22%	54,823 $1.45 Million
Q3 2021 Nov 12, 2021	SELL	$100.0 - $143.02 $1.02 Million - $1.45 Million	-10,170 Reduced 14.68%	59,090 $5.94 Million
Q2 2021 Aug 06, 2021	BUY	$78.27 - $151.29 $806,337 - $1.56 Million	10,302 Added 17.47%	69,260 $9.8 Million
Q1 2021 May 10, 2021	SELL	$94.25 - $132.81 $3,298 - $4,648	-35 Reduced 0.06%	58,958 $5.88 Million
Q4 2020 Feb 10, 2021	BUY	$102.03 - $184.62 $423,934 - $767,096	4,155 Added 7.58%	58,993 $7.3 Million
Q3 2020 Nov 13, 2020	BUY	$93.53 - $163.34 $5.13 Million - $8.96 Million	54,838 New	54,838 $5.34 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.